Cutting Edge Glaucoma - Issue 2

TWO-YEAR RESULTS OF A MULTICENTER STUDY OF THE AB INTERNO GELATIN IMPLANT IN MEDICALLY... • 43  Open Access This article is distributed under the terms of the Creative Commons Attribution 4 .0 International License (http://creativecom- mons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References 1. American Academy of Ophthalmology (2015) Primary open-angle glaucoma—preferred practice pattern. http://www.aaojournal.org/article/S0161-6420( 15)01276-2/pdf. Accessed January 23, 2018. 2. European Glaucoma Society Terminology and guidelines for glaucoma (4th edition). https://www.eugs.org/ eng/guidelines.asp. Accessed January 23, 2018. 3. Lichter PR, MuschDC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP, CIGTS Study Group (2001) Interimclinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943–1953. https://doi.org/10.1016/S01616420 (01)00873-9 4. Feiner L, Piltz-Seymour JR (2003) Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 14:106–111. 5. Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE (2005) Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 140:16–22. https://doi.org/10.1016/j.ajo.2005.02.013 6. Zahid S, Musch DC, Niziol LM, Lichter PR (2013) Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol 155:674–680. e1. https://doi.org/10.1016/j.ajo.2012.10.017 7. Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650–663. https://doi. org/10.1016/j.ophtha.2018.02.003 8. Vera VI, Horvath C (2014) XEN gel stent: the solution designed by AqueSys®. In: Samples JR, Ahmed IIK (eds) Surgical innovations in glaucoma. Springer Science+Business Media, New York, pp 189–198. 9. Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE (2011) Randomized evaluation of the trabecular micro- bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 118:459–467. https://doi.org/10.1016/j.ophtha. 2010.07.007 10. Vold S, Ahmed IIK, Craven ER, Mattox C, Stamper R, Packer M, Brown RH, Ianchulev T (2016) Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology 123: 2103–2112. https://doi.org/10.1016/j.ophtha.2016.06.032 11. Caprioli J, Kim JH, Friedman DS, Kiang T, Moster MR, Parrish RK 2nd, Rorer EM, Samuelson T, Tarver ME, Singh K, Eydelman MB (2015) Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology 122:1795–1801. https://doi.org/10.1016/j. ophtha. 2015.02.029 12. De Gregorio A, Pedrotti E, Russo L, Morselli S (2017) Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol 38:1129–1134. https://doi.org/10.1007/ s10792-017-0571-x 13. Galal A, Bilgic A, Eltanamly R, Osman A (2017) XEN glaucoma implant with mitomycin C 1-year follow-up: result and complications. J Ophthalmol 2017:5457246. https://doi.org/10.1155/2017/5457246 14. Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I (2017) Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma 26: 1130–1136. https:// doi.org/10.1097/ijg.0000000000000803 15. Sng CC, Wang J, Hau S, Htoon HM, Barton K (2017) XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol 46:339–34. https://doi.org/10.1111/ceo.13087 16. Mansouri K, Guidotti J, Rao HL, Ouabas A, D’Alessandro E, Roy S, Mermoud A (2018) Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN Gel implant surgery: 1-year results. J Glaucoma 27:140–147. https://doi.org/10.1097/IJG.0000000000000858 17. Tan SZ, WalkdenA, Au L (2018) One-year result of XEN45 implant for glaucoma: efficacy, safety, andpostoperative management. Eye 32:324–332. https://doi.org/10.1038/eye.2017.162 18. Ibáñez-Muñoz A, Soto-Biforcos VS, Chacón-González M, RúaGalisteo O, Arrieta-Los Santos A, Lizuain-Abadia ME, Del Río Mayor JL (2018) One-year follow-up of the XEN(R) implant with mitomycin-C in pseudoexfoliative glaucoma patients. Eur J Ophthalmol. https://doi.org/10.1177/1120672118795063